Research concepts, not treatment offers
The portfolio includes wellness-oriented and scalp-care directions alongside cosmetic formats. They are presented here as R&D concepts and configuration references, not finished treatments, approved medicines or verified clinical outcomes. The ingredient profiles describe separate formulations, not interchangeable combinations.
Sleep-oriented patch concept
- Array material
- Hyaluronic acid (HA)
- Nominal needle height
- 300–1,000 µm
- Needles per patch
- 150
- Patches per pack
- 1 / 2 / 3 / 6 / 8 / 9
- Customization
- Backing, tray, color and dimensions
Geometry-led sleep profile
Ingredient reference: Melatonin, gamma-aminobutyric acid (GABA) and sour jujube seed extract
Sleep-related research concept
Additional sleep-support profile
Ingredient reference: GABA, vitamin B6, melatonin, sodium hyaluronate and valerian root extract
Pack reference: 6 / 9 patches
The catalogue describes sleep support and sleep difficulties associated with tension and anxiety; this is an unvalidated positioning reference, not a treatment claim
Not offered as a ready-to-use treatment for insomnia, anxiety or any sleep disorder.
Portfolio pp. 17, 20
Body-shaping patch concepts
- Array material
- Hyaluronic acid (HA)
- Nominal needle height
- 300–1,000 µm
- Needles per patch
- 500
- Catalogue wear-time reference
- 3–6 hours
- Backing options
- PE / PU / TPU / hydrocolloid
- Other options
- Dimensions, color and tray
Array-led catalogue profile
Ingredient reference: GLP-1-related active ingredients. The catalogue does not specify an active identity, dose or exposure.
Body-shaping patchs research direction
Separate capsaicin / HA profile
Ingredient reference: Capsaicin, HA in three molecular-weight grades, plant-derived salicin and niacinamide
Pack reference: 3 / 4 patches
Catalogue body-shaping and metabolism-support research; not equivalent to the GLP-1-related profile
Body-shaping is the catalogue concept name, not demonstrated weight loss or metabolic efficacy.
Portfolio pp. 18, 19, 20
Alcohol-metabolism patch concept
- Array material
- Hyaluronic acid (HA)
- Nominal needle height
- 300–1,000 µm
- Needles per patch
- 500
- Catalogue wear-time reference
- 3–6 hours
- Backing options
- PE / PU / TPU / hydrocolloid
- Other options
- Dimensions, color and tray
Array-led catalogue profile
Ingredient reference: Alcohol dehydrogenase and aldehyde dehydrogenase.
Alcohol-metabolism patch research direction
No prevention or reversal of intoxication, detoxification, hangover relief or safer alcohol consumption is established.
Portfolio pp. 18, 19
Joint-care patch concept
- Array material
- Hyaluronic acid (HA)
- Nominal needle height
- 300–1,000 µm
- Needles per patch
- 1500
- Catalogue wear-time reference
- 3–6 hours
- Backing options
- PE / PU / TPU / hydrocolloid
- Other options
- Dimensions, color and tray
Array-led catalogue profile
Ingredient reference: Turmeric-derived extracellular vesicles and Dipsacus-derived extracellular vesicles.
Joint-care patch research direction
No treatment of joint pain, inflammation, arthritis or tissue repair is established.
Portfolio pp. 18, 19
Nasal-care patch concept
- Array material
- Hyaluronic acid (HA)
- Nominal needle height
- 300–1,000 µm
- Needles per patch
- 500
- Catalogue wear-time reference
- 3–6 hours
- Backing options
- PE / PU / TPU / hydrocolloid
- Other options
- Dimensions, color and tray
Array-led catalogue profile
Ingredient reference: Xanthium fruit, Centipeda minima, magnolia flower bud and honeysuckle extracts.
Nasal-care patch research direction
A catalogue array concept, not authorization for intranasal placement or treatment of rhinitis. Botanical identity and toxicological suitability require review.
Portfolio pp. 18, 19
Smoking-cessation patch concept
- Array material
- Hyaluronic acid (HA)
- Nominal needle height
- 300–1,000 µm
- Needles per patch
- 3000
- Catalogue wear-time reference
- 3–6 hours
- Backing options
- PE / PU / TPU / hydrocolloid
- Other options
- Dimensions, color and tray
Array-led catalogue profile
Ingredient reference: Broom-flower extract, kudzu extract and Houttuynia extract.
Smoking-cessation patch research direction
Additional botanical profile
Ingredient reference: A blend of botanical extracts; identities and proportions not supplied
Catalogue nicotine-craving management, emotional balance and relapse-urge support; not validated outcomes
The common name broom-flower does not identify a botanical species. Confirm the exact species. No nicotine-craving reduction, emotional-balance effect or relapse prevention is established.
Portfolio pp. 18, 19, 20
Hair & scalp-care patch concept
- Patches per pack
- 4 / 6 / 9 / 12
- Array geometry
- Project-specific; no count or height supplied for this profile
Scalp-care profile
Ingredient reference: Edelweiss-derived exosomes, Tripeptide-1 and Type XIV collagen
The catalogue describes follicle activation, growth-phase support and scalp condition; none is established as a finished-product result
Confirm extracellular-vesicle / exosome identity, origin, characterization, ingredient nomenclature and regulatory status. No hair-regrowth or alopecia-treatment claim is made.
Portfolio pp. 20
Separate packs and separate evidence
The geometry-led sleep concept lists 1 / 2 / 3 / 6 / 8 / 9 patches per pack. The separate GABA, vitamin B6, melatonin and valerian profile lists 6 / 9. The capsaicin body profile lists 3 / 4. The scalp-care profile lists 4 / 6 / 9 / 12. Do not transfer needle counts or wear-time references to configurations where the portfolio supplies none.
Begin with identity, classification and feasibility
A GLP-1-related reference does not identify the active substance, dose, release rate or systemic exposure. It does not establish a Retatrutide product, equivalence to an approved medicine or weight-loss performance. Enzymes, botanicals, extracellular vesicles, exosomes, peptides and collagen each need identity, source, quality and route-specific safety review.
The listed wear times are source references, not instructions for self-use. No insomnia, anxiety, intoxication, joint disease, rhinitis, smoking dependence or hair-loss treatment claim is established by this portfolio.
Read the GLP-1 / Retatrutide scope guide → · Discuss an appropriately scoped research brief →